Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath
-
Published:2024-02
Issue:
Volume:222
Page:107534
-
ISSN:0954-6111
-
Container-title:Respiratory Medicine
-
language:en
-
Short-container-title:Respiratory Medicine
Author:
Taylor Matthew J.,
Chitwood Corey P.,
Xie Zhenzhen,
Miller Hunter A.,
van Berkel Victor H.ORCID,
Fu Xiao-An,
Frieboes Hermann B.ORCID,
Suliman Sally A.
Funder
University of Louisville
Reference49 articles.
1. Inflammation, Wound healing, and fibrosis;Ghatak,2018
2. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11;Raghu;Lancet Respir. Med.,2014
3. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline;Raghu;Am. J. Respir. Crit. Care Med.,2022
4. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases;Chiu;Respir. Med.,2021
5. Differentiation of idiopathic pulmonary fibrosis from connective tissue disease-related interstitial lung disease using quantitative imaging;Chung;J. Clin. Med.,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献